MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

NCT00239759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2009-02-25

No results posted yet for this study

Summary

The goal of MIRAGE is to evaluate the association of genetic and non-genetic risk factors for Alzheimer's Disease.

Conditions

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Lindsay Farrer, PhD · Chief, Genetics Program, Boston University

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-09-30
Completion
2008-06-30

Countries

  • United States
  • Canada
  • Germany
  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239759 on ClinicalTrials.gov